Sunday, August 9, 2020
Home Life Style Health & Fitness Two of Four Experimental Ebola Drugs Tests in Congo Saving Lives

Two of Four Experimental Ebola Drugs Tests in Congo Saving Lives

The preliminary findings prompted an early halt to a major study on the drugs and a decision to prioritize their use in the African country

Two of four experimental Ebola drugs being tested in Congo seem to be saving lives, international health authorities announced Monday.

The preliminary findings prompted an early halt to a major study on the drugs and a decision to prioritize their use in the African country, where a yearlong outbreak has killed more than 1,800 people.

The early results mark “some very good news,” said Dr. Anthony Fauci of the U.S. National Institutes of Health, which helped fund the study. With these drugs, “we may be able to improve the survival of people with Ebola.”

The two drugs — one developed by Regeneron Pharmaceuticals and the other by NIH researchers — are antibodies that work by blocking the virus.

Ebola, Drugs, Congo
FILE – A man receives a vaccine against Ebola from a nurse outside the Afia Himbi Health Center in Goma, July 15, 2019. VOA

While research shows there is an effective albeit experimental vaccine against Ebola — one now being used in Congo — no studies have signaled which of several potential treatments were best to try once people became sick. During the West Africa Ebola epidemic several years ago, studies showed a hint that another antibody mixture named ZMapp worked, but not clear proof.

So with the current outbreak in Congo, researchers compared ZMapp to three other drugs — Regeneron’s compound, the NIH’s called mAb114 and an antiviral drug named remdesivir.

On Friday, independent study monitors reviewed how the first several hundred patients in the Congo study were faring — and found enough difference to call an early halt to the trial. The panel determined that the Regeneron compound clearly was working better than the rest, and the NIH antibody wasn’t far behind, Fauci explained. Next, researchers will do further study to nail down how well those two compounds work.

The data is preliminary, Fauci stressed. But in the study, significantly fewer people died among those given the Regeneron drug or the NIH’s — about 30% compared to half who received ZMapp. More striking, when patients sought care early — before too much virus was in their bloodstream — mortality was just 6% with the Regeneron drug and 11% with the NIH compound, compared to about 24% for ZMapp, he said.

Also Read- Trump Administration Significantly Weakens U.S. Endangered Species Act

Among people who receive no care in the current outbreak, about three-fourths die, said Dr. Michael Ryan of the World Health Organization. All of Congo’s Ebola treatment units have access to the two drugs, he added, saying he was hopeful that the news would persuade more patients to seek care — as soon as symptoms appear.

Quick care ‘vital’

Tackling Congo’s outbreak has been complicated both by conflict in the region and because many people don’t believe Ebola is real and choose to stay at home when they’re sick, which spurs spread of the virus.

“Getting people into care more quickly is absolutely vital,” Ryan said. “The fact that we have very clear evidence now on the effectiveness of the drugs, we need to get that message out to communities.”

Ebola, Drugs, Congo
Two of four experimental Ebola drugs being tested in Congo seem to be saving lives, international health authorities announced Monday. Pixabay

Fauci said Regeneron and Ridgeback Biotherapeutics, which has licensed the NIH compound, told authorities enough doses are readily available.

Also Read- Amazon Launches its Marketplace Appstore in India

One issue researchers will have to analyze: Occasionally people who receive the Ebola vaccine still become sick, including some in the treatment study, which raises the question of whether their earlier protection inflated the drugs’ survival numbers. (VOA)

STAY CONNECTED

18,958FansLike
362FollowersFollow
1,780FollowersFollow

Most Popular

Redecorating Your Home Amid Pandemic

By Puja Gupta After coping with the sudden disruption caused by the lockdown, families across India are now settling down to make the best of...

94% People Feel Happier When Outdoors: Survey

By SIddhi Jain Social distancing norms is the ''new normal" and it has the world spending more time indoors than ever, but a new survey...

Assisted Living Homes and Their Importance for Elderly People

By Siddhi Jain Shrinking family sizes, lack of awareness about age-related conditions and availability of specialised care homes for the elderly are some of the...

Understand the Procedure and Importance of IVF

By Puja Gupta According to WHO, every 1 in 8 couples (or 12 per cent of married women) has gone through complexities getting pregnant or...

Try These Recipes to Get Super Charged with Nutrients you Need

By Simrun Chopra 2020 is unlike any year we have seen and in parts of the country this monsoon is unlike any we have seen. Staying...

Sidharth Malhotra has Felt a Wide Range of Emotions this Year

Actor Sidharth Malhotra has felt a wide range of emotions over the past few months. When the year 2020, started, he enjoyed some relaxing time,...

How Relevant Is The Existence Of Censor Board Of Film Certification?

There is a curious situation vis a vis the Censor Board of Film Certification! How relevant is its existence now? The Board, which was...

Vidyut Jammwal Reveals Secret of his Upper Body Strength in a Video

Action star and fitness enthusiast Vidyut Jammwal has revealed the secret of his upper body strength. Vidyut has uploaded a video of him performing Kalari...

Recent Comments